drugset
drugset / Trial / NCT03196843

Radiotherapy Combine With Raltitrexed Versus Radiotherapy Alone in Older Patients With HNSCC.

NCT03196843 ↗

Phase 4 Unknown 202 enrolled The First Affiliated Hospital of Dalian Medical University
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the efficacy of radiotherapy combine with raltitrexed in older patients with head and neck squamous cell carcinoma.

Timeline

Start
2017-09-01
Primary completion
2020-08
Completion
2023-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Raltitrexed Small molecule 2.5 mg/m2 Intravenous

Indications

head and neck squamous cell carcinoma